Provides certain controls over prescription drug costs by imposing transparency, oversight and accountability requirements on commercial insurers and their pharmacy benefit managers.
Provides an insurer would not impose prior authorization requirements for any service ordered by an in-network primary care provider.
Provides an insurer would not impose prior authorization requirements for any service ordered by an in-network primary care provider.
Prohibits an insurer from imposing a requirement of prior authorization for any admission, item, service, treatment or procedure ordered by a primary care provider.
Would promote transparency and accountability in the use of artificial intelligence by health insurers to manage coverage and claims.
Would promote transparency and accountability in the use of artificial intelligence by health insurers to manage coverage and claims.
Limits the use by insurers of step therapy, a protocol that establishes a specific sequence in which prescription drugs for a specified medical condition are covered by an insurer, by allowing medical providers to request step therapy exceptions.
Limits the use by insurers of step therapy, a protocol that establishes a specific sequence in which prescription drugs for a specified medical condition are covered by an insurer, by allowing medical providers to request step therapy exceptions.